Day One Biopharmaceuticals Inc Cash Flow Quality Index
Day One Biopharmaceuticals Inc cash flow quality index. Day One Biopharmaceuticals Inc (DAWN) has a Cash Flow Quality Index of 1.37x as of September 2024. Operating cash flow of $50.75 Million exceeds net income of $37.04 Million, indicating high earnings quality where cash backs reported profits. Explore DAWN operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Day One Biopharmaceuticals Inc Cash Flow Quality Index by Year (None–None)
Day One Biopharmaceuticals Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Day One Biopharmaceuticals Inc. For the full cash flow conversion analysis, see DAWN operating cash flow.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|